SETD1A
protein-codingSET domain containing 1A, histone lysine methyltransferase, the group of SET domain containing|RNA binding motif containing|Lysine methyltransferases
Gene summary
The protein encoded by this gene is a component of a histone methyltransferase (HMT) complex that produces mono-, di-, and trimethylated histone H3 at Lys4. Trimethylation of histone H3 at lysine 4 (H3K4me3) is a chromatin modification known to generally mark the transcription start sites of active genes. The protein contains SET domains, a RNA recognition motif domain and is a member of the class V-like SAM-binding methyltransferase superfamily. [provided by RefSeq, Dec 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~27.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0030005
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0033630
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0030005
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0033630
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SETD1A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014712.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 139 | 4 | 149 | |
| missense | 3 | 15 | 523 | 110 | 1 | 652 |
| nonsense | 9 | 16 | 3 | 28 | ||
| start loss | 0 | |||||
| frameshift | 25 | 18 | 7 | 50 | ||
| splice donor/acceptor (+/-2bp) | 2 | 3 | 6 | 1 | 12 | |
| Total | 39 | 53 | 544 | 250 | 5 | 891 |
Highest pathogenic variant AF is 0.00006915832
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055527.1 | 18 | MANE Select | |
| Ensembl | ENSP00000262519.8 | 18 | MANE Select | |
| Ensembl | ENSP00000391408.3 | 2 | Standard | |
| Ensembl | ENSP00000508271.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Lysine degradation - Homo sapiens (human)
- Histone Modifications
- Gene expression (Transcription)
- Generic Transcription Pathway
- PKMTs methylate histone lysines
Biological Process
- regulation of megakaryocyte differentiation
- histone H3-K4 methylation
- regulation of hematopoietic stem cell differentiation
- regulation of chromatin organization
Molecular Function
- RNA binding
- protein binding
- beta-catenin binding
- transcription factor binding
- histone-lysine N-methyltransferase activity
Cellular Component
- nuclear chromatin
- nucleus
- nucleoplasm
- nuclear speck
- histone methyltransferase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000262519
- Coding exons
- 18
- Length
- 27823
- Individuals with no LoFs
- 125738
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 10
- Defined
- 125748
- p
- 0.0000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.83 | 922 | 1.09e+3 | 0.844 | 0.0000756 | 10843 |
| Missense (PolyPhen) | 93 | 139.34 | 0.66744 | 1308 | ||
| Synonymous | -4.19 | 579 | 464 | 1.25 | 0.0000328 | 3652 |
| Loss of Function | 7.15 | 4 | 67.2 | 0.0595 | 0.00000372 | 747 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000066 | 0.000062 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.000046 | 0.000044 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Histone methyltransferase that specifically methylates 'Lys-4' of histone H3, when part of the SET1 histone methyltransferase (HMT) complex, but not if the neighboring 'Lys- 9' residue is already methylated. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. The non-overlapping localization with SETD1B suggests that SETD1A and SETD1B make non-redundant contributions to the epigenetic control of chromatin structure and gene expression. {ECO:0000269|PubMed:12670868}.;
Intolerance Scores
- LoFtool
- 0.00654
- RVIS EVS
- -2.93
- RVIS percentile EVS
- 0.56
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.988
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |